Stephenson Pamela 4
4 · Disc Medicine, Inc. · Filed Feb 11, 2026
Research Summary
AI-generated summary of this filing
Disc Medicine (IRON) CCO Pamela Stephenson Receives Awards
What Happened
Pamela Stephenson, Chief Commercial Officer of Disc Medicine (IRON), received two equity awards on February 10, 2026: 17,000 restricted stock units (RSUs) and 25,500 derivative awards (option-like). Both awards were granted at $0.00 (no cash paid at grant); the filing does not state an immediate cash value or resulting change in share ownership.
Key Details
- Transaction date: 2026-02-10; Form 4 filed 2026-02-11 (timely filing).
- Awards: 17,000 RSUs (footnote F1) and 25,500 derivative award units/options (footnote F2).
- Grant price: $0.00 for both lines (standard for equity grants).
- Vesting: RSUs vest annually in four equal (25%) installments beginning Feb 15, 2027 (F1). The derivative award's underlying shares vest in 48 equal monthly installments beginning March 10, 2026 (F2).
- Shares owned after transaction: not specified in the filing.
- Transaction code: A = Award/Grant. No sale or exercise occurred.
Context
These are compensation awards rather than open-market purchases or sales. RSUs convert to shares as they vest; the derivative award appears to be an option or similar instrument whose shares vest monthly. Grants at $0.00 are common for employee compensation and do not by themselves indicate buying or selling activity.
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-10+17,000→ 86,529 total - Award
Stock Option (Right to Buy)
[F2]2026-02-10+25,500→ 25,500 totalExercise: $74.75Exp: 2036-02-09→ Common Stock (25,500 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest annually in four 25% installments commencing on February 15, 2027, subject to the Reporting Person's continued service on each such vesting date.
- [F2]The shares underlying this option vest in 48 equal monthly installments commencing on March 10, 2026, subject to the Reporting Person's continued service on each such vesting date.